can glp 1 cause skin sensitivity Allodynia and semaglutide: complete guide to GLP-1 pain A Closer Look at the

Glucagon-like peptide-1 (GLP-1) agonists are the latest evolution of drugs that are reshaping the way we treat diabetes, obesity, and other forms of addiction.

Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses.

Long-term adherence is essential to realizing the full therapeutic potential of GLP-1s, yet behavioral factors (such as reaching personal weight goals or perceived social stigma) and systemic issues (like high out-of-pocket costs and fragmented care) disproportionately affect obesity patients

Yet deep-vein thrombosis puts more t...

Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.